Dhanabalan, K. et al. 2022. #48 A novel UPLC method development, validation and forced degradation studies on Lamivudine and Dolutegravir in combined pharmaceutical dosage form. Journal of Pharmaceutical Chemistry. 8, Supplement (Jul. 2022).